Starton Therapeutics Inc. — Form D

Starton Therapeutics Inc. of PARAMUS, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-13. $2.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
ROMAN ROGOLDirectorNEW YORK, NY
ROY WALDONDirectorFORT LAUDERDALE, FL
Nitin KaushalDirectorKelowna, A1
Scott KahnExecutive OfficerParamus, NJ
Mohamad HusseinDirectorMelbourne Beach, FL
Eric BaumDirectorCharlotte, NC
Roy WaldronDirectorFort Lauderdale, FL
Asher Chanan-KhanDirectorJacksonville, FL
Pedro Lichtinger WaismanDirectorSunny Isles Beach, FL
Pedro Lichtinger WaismanExecutive OfficerSunny Isles Beach, FL
Kenneth AndersonDirectorWellesley, MA
Moses DodoDirectorCoral Gables, FL
Fotios PlakogiannisDirectorWhitestone, NY
Jamie OliverExecutive OfficerRaleigh, NC
Cidnee VaykovichDirectorNew York, NY
Cidnee VaykovichExecutive OfficerNew York, NY
Keith DarraghExecutive OfficerParamus, NJ
Pedro WaismanDirectorParamus, NJ
Pedro WaismanExecutive OfficerParamus, NJ
PEDRO LICHTINGERDirectorPARAMUS, NJ
PEDRO LICHTINGERExecutive OfficerPARAMUS, NJ
LITSA PERPERIDISPromoterPARAMUS, NJ
Nintin KaushalDirectorNew York, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2024-10-22D$2.1M$2.1M
2023-10-13D$971K$971K
2023-04-13D$1.4M$1.4M
2023-01-25D$1.0M$1.0M
2022-02-16D$1.1M$1.1M
2021-11-22D$1.1M$1.1M
2021-05-26D$78K$78K
2018-07-02D$767K

More